Health Care

Homeopathic products test positive for urinary tract and antibiotic-resistant bacteria

AP file

HelloLife issued what it calls a “worldwide recall” of four homeopathic products, one of which tested positive for a bacteria that causes urinary tract infections and another for a bacteria that’s often invulnerable to antibiotics.

Neuroveen, Compulsin, Respiritol and Thyroveev all were produced at the Asheville, North Carolina, facility of King Bio, which recalled all its water-based medicines earlier this week because of what it called a “water purity problem.” From that problem could grow microbial contaminations.

Read Next

Read Next

“Neuroveen has been tested and found to be contaminated with Staphylococcus saprophyticus and Burkholderia cepacia. Compulsin has been identified as containing Burkholderia cepacia,” HelloLife said in the company-written, FDA-posted recall notice. “Respitrol and Thyroveev are still pending bacterial identification.”

Advocacy group U.S. PIRG said, “We are glad that the FDA strengthened its enforcement of homeopathic drugs last year, but this latest recall is another reminder that the current efforts are insufficient to protect our children, families, and pets at risk. Our concern is that the risk-based approach will let unsafe products, by the FDA’s own admission, slip through the cracks.

“If homeopathic drugs want to be labeled as “drugs”, they should be treated as such with all the accompanying mechanisms to ensure that these products are adequately tested before they hit our store shelves instead of after.”

Staphylococcus saprophyticus is, according to the National Center for Biotechnology Information, “a common cause of uncomplicated urinary tract infections (UTIs), particularly in young sexually active females. Less commonly, it is responsible for complications including acute pyelonephritis, urethritis, epididymitis, and prostatitis.”

As for Burkholderia cepacia, the Centers for Disease Control says it’s “the name for a group or “complex” of bacteria that can be found in soil and water. B. cepacia bacteria are often resistant to common antibiotics.”

But, the CDC also notes, Burkholderia cepacia rarely threatens the fully healthy. Those with damaged immune systems or lung problems might be more likely to be infected. That being the case, it’s no surprise that “B cepacia is a known cause of infections in hospitalized patients.”

Read Next

One lot of each product, each with an expiration date of July 2019 and in 2-ounce bottles, is being recalled.

Lot No. NV/030717D is Neuroveen, marketed as relieving nerve pain.

neuroveen.JPG
HelloLife via FDA

Lot No. RE/030717E is Respiritol, marketed as relieving respiratory problems.

respiratol.JPG
HelloLife via FDA

Lot No. TVV/030717F is Thyroveev, marketed as relieving “sluggish thyroid” symptoms.

thyroveev.JPG
HelloLife via FDA

Lot. No. CO/030717B is Compulsin, marketed as being for “nervous repetitive thought/behavior relief.”

compulsin.JPG
Hellolife via FDA

Customers with questions can call HelloLife at 616-803- 7243, Monday through Friday, 9:00 a.m. to 5:00 p.m, Eastern time.

  Comments